PBV Insights
Log In Get Started
News
21 Oct 2025

Latham & Watkins Advises Veracyte Inc. on Sale of French Subsidiary to Helio Diagnostics SAS

"Latham & Watkins advised Veracyte Inc. on the sale of its French subsidiary, Veracyte SAS, to Helio Diagnostics SAS. The Paris team was led by restructuring partner Hervé Diogo Amengual and associate Lucas Lo Cascio."

Latham & Watkins advised Veracyte Inc., a leader in cancer screening, in the sale of its French subsidiary, Veracyte SAS, to Helio Diagnostics SAS. The transaction involved the divestiture of Veracyte SAS, allowing Veracyte Inc. to streamline its operations and focus on its core business in cancer diagnostics. The Latham & Watkins team was led by Hervé Diogo Amengual, a partner in restructuring based in Paris, along with Lucas Lo Cascio, an associate in restructuring.
Read the full story

Register for free to access daily news.

Register Free
Already registered? Login
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.